Published in Blood Weekly, February 3rd, 2005
The EPA on January 12, 2005, said that exposure to even low levels of perfluorooctanoic acid and its salts, known as PFOA, or C-8, could pose "a potential risk of developmental and other adverse effects." Officials emphasized their draft risk assessment was not conclusive.
"We've not offered any determinations of risks," said Charles Auer, director of EPA's Office of Pollution Prevention and Toxics.
Auer said the draft report, based on animal studies, would be sent to a science...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.